Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders
- 18 December 1995
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 60 (6) , 563-565
- https://doi.org/10.1002/ajmg.1320600616
Abstract
The principal brain synaptic vesicular monoamine transporter (VMAT2) is responsible for the reuptake of serotonin, dopamine, nor‐epinephrine, epinephrine, and histamine from the cytoplasm into synaptic vesicles, thus contributing to determination of the size of releasable neurotransmitter vesicular pools. Potential involvement of VMAT2 gene variants in the etiology of schizophrenia and related disorders was tested using polymorphic VMAT2 gene markers in 156 subjects from 16 multiplex pedigrees with schizophrenia, schizophreniform, schizoaffective, and schizotypal disorders and mood incongruent psychotic depression. Assuming genetic homogeneity, complete (θ = 0.0) linkage to the schizophrenia spectrum was excluded under both dominant and recessive models. Allelic variants at the VMAT2 locus do not appear to provide major genetic contributions to the etiology of schizophrenia spectrum disorders in these pedigrees. © 1995 Wiley‐Liss, Inc. 1 This article is a U.S. Government work and, as such, is in the public domain in the United States of America.Keywords
This publication has 12 references indexed in Scilit:
- Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disordersAmerican Journal of Psychiatry, 1995
- Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profileMolecular Brain Research, 1994
- The Roscommon Family StudyArchives of General Psychiatry, 1993
- A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPsFEBS Letters, 1993
- A Linkage Study of Chromosome 11q in SchizophreniaArchives of General Psychiatry, 1993
- Published by American Medical Association (AMA) ,1993
- The transport of neurotransmitters into synaptic vesiclesCurrent Opinion in Neurobiology, 1992
- A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporterCell, 1992
- Twin Concordance for DSM-III SchizophreniaArchives of General Psychiatry, 1987
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976